HopeStage
Back to all studies
CompletedNCT04584879

Personalizing therapy for anxiety, depression, PTSD, and OCD

About this titleRead the official source — NCT04584879

This study assessed anxiety symptoms.

Behavioural studyAges 18+United States
The study in practice

Understand this study

What did researchers investigate?

This study assessed anxiety symptoms.

Who was this study for?

Listed age limits: from 18 years.

Listed locations
LexingtonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 28, 2019
Recruitment status
Completed
Enrollment listed in the registry
72
Sponsor
Shannon E. Sauer-Zavala
Sponsor type
Individual investigator
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04584879
Official title
Show the full official title

Transdiagnostic Treatment Personalization: Prioritizing Therapy Components to Capitalize on Strengths or Compensate for Weaknesses

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Lexington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study assessed anxiety symptoms.

Who is behind this study?

The study sponsor is Shannon E. Sauer-Zavala.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies